Welcome to our dedicated page for Enova Intl SEC filings (Ticker: ENVA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how Enova International funds high-velocity online loans or how rising delinquency rates impact margins often requires piecing together hundreds of pages across multiple forms. From securitization footnotes to state-specific lending caps, the disclosures can be daunting. If you’ve ever searched for “Enova International insider trading Form 4 transactions” or “Enova International quarterly earnings report 10-Q filing,” you know the challenge: the data exists, but it’s scattered.
Stock Titan solves that problem. Our AI-powered engine delivers “Enova International SEC filings explained simply,” turning raw documents into clear insights. Need “Enova International Form 4 insider transactions real-time” alerts? We surface them the moment they hit EDGAR and highlight which executive bought or sold. Want an “Enova International annual report 10-K simplified” walkthrough that pinpoints credit loss trends, funding costs, and regulatory risks? One click. Our coverage spans every filing type—10-Q, 8-K, DEF 14A, S-3—plus redlined comparisons and keyword search, so “understanding Enova International SEC documents with AI” becomes part of your daily workflow.
The platform connects filing types to what matters for a consumer-lending fintech. The 10-Q reveals net charge-offs; we transform that into a quarter-over-quarter chart for “Enova International earnings report filing analysis.” The proxy shows “Enova International proxy statement executive compensation,” including pay metrics tied to loan performance. Form 4 feeds flag “Enova International executive stock transactions Form 4,” letting you monitor insider sentiment before headlines move the stock. Even sudden disclosures are covered: “Enova International 8-K material events explained” highlights funding facility amendments or regulator inquiries within minutes. With real-time updates, AI summaries, and expert commentary, you can act on complete information instead of searching for it.
Enova International, Inc. (NYSE: ENVA) – Form 144 notice
Insider James Lee intends to sell up to 478 common shares through Morgan Stanley Smith Barney, with an estimated aggregate value of $50,484. The planned trade may occur on or after 29 Jul 2025 on the NYSE. Relative to the 25.0 million shares outstanding, the sale equals roughly 0.002 %, indicating a de-minimis transaction. The shares originate from restricted-stock grants received on 9 and 11 Feb 2024 (359 and 119 shares). Lee previously sold 550 shares on 2 May 2025 for $52,109.
The filing is procedural under Rule 144 and does not disclose any operational or financial developments. Given the very small size, it is unlikely to influence ENVA’s capital structure, liquidity, or share-price dynamics.
Form 4 highlights for Enova International, Inc. (ENVA): On 06/20/2025, Chief Executive Officer and Director David Fisher exercised 2,000 non-qualified stock options at an exercise price of $23.96 (code “M”) and immediately sold the same 2,000 common shares in the open market at a weighted-average price of $98.4214 (code “S”).
• Gross spread captured: approximately $74.46 per share, or roughly $149,000 in pre-tax proceeds.
• Remaining direct ownership: 348,223 common shares after the transactions, down from 350,223.
• Outstanding options: 170,562 options remain unexercised on the same grant, expiring 02/12/2026. The option set vested in three equal tranches between 2020 and 2022.
The sale was executed under Fisher’s established Rule 10b5-1 trading plan, limiting the informational signal for investors. The option/SAR pair was granted with a limited stock-appreciation right that becomes exercisable only upon a Change in Control scenario; exercising the option automatically terminates the corresponding SAR.
Materiality assessment: The transaction represents less than 1% of Fisher’s total common-stock holdings and does not involve new share issuance or company-level cash flows. Therefore, the filing is viewed as routine insider portfolio management, with negligible direct effect on Enova’s capital structure or near-term financial outlook.